video

On-demand webinar: Leveraging advances in predesigned synthetic sgRNA for highly functional and specific CRISPR-Cas9 gene knockout

Posted: 11 September 2020 | | No comments yet

This webinar explains how synthetic guide RNAs are stable, eliminate cloning and sequencing steps, and avoid innate immune responses and cytotoxicity.

Leveraging advances in predesigned synthetic sgRNA

This on-demand webinar explains how synthetic guide RNAs are amenable to chemical modifications for increased stability, eliminate time-consuming steps of cloning and sequencing, and do not provoke the inherent immune response and cytotoxicity of in vitro transcribed guide RNAs. They can be readily delivered into cells for high-throughput arrayed screening applications and expand the types of phenotypic readouts to high-content and morphology-based assays.

    To read this application note in full, please complete the form below:

     










    This specialist content is provided to you free-of-charge thanks to the kind support of Horizon Discovery

    By clicking submit you confirm that you accept our terms and conditions and privacy policy.